БОК, Марк (US),ХАО, Мин-Хун (US),КОРПАЛ, Манав (US),НЬЯВАНАНДИ, Виджай Кумар (IN),ПУЯН, Сяолин (US),САМАДЖДАР, Сусанта (IN),СМИТ, Питер Джерард (US),ВАН, Джон (US),ЧЖЭН, Го Чжу (US),ЧЖУ, Пин (US)
申请号：
RU2017146408
公开号：
RU2017146408A
申请日:
2016.05.27
申请国别(地区):
RU
年份:
2019
代理人:
摘要：
Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast cancer may be an ER-positive breast cancer and/or the subject in need of treatment may express a mutant ER-α protein.
